Definitive Contract 75F40123C00187
Award Date
9/18/23
Potential Completion Date
9/19/25
Potential Value
$167K
Federal Agency
Food and Drug Administration
Awardee
Sage Bionetworks
Ultimate Awardee
Not listed
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98121, USA
Solicitation Procedures
Two Step
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Sage Bionetworks, a nonprofit organization. The contract is for the "PEGS DREAM CHALLENGE" with a ceiling value of $210,000.00 and an ultimate completion date of August 30, 2024. The contract does not have a set-aside designation. Sage Bionetworks is an experienced federal contractor that has provided data coordination, platform...
The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $2,450,090 delivery order contract to Sage Bionetworks of Seattle, Washington. The contract has a period of performance from August 2, 2022 through July 10, 2025 and utilizes a time and materials pricing structure. Sage Bionetworks will provide SUPPORT AOURP AND (RCO) services under major program code support to the funding agency. No subcontractors or additional...
This federal contract award, valued at $811,126.00, was issued by the U.S. Food and Drug Administration (FDA) to Digital Medicine Society Inc., a non-profit organization based in Boston, Massachusetts. The contract was awarded under a Broad Agency Announcement (BAA) solicitation for research and development to support the FDA's regulatory science and innovation mission. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and has an ultimate completion date of December 31,...
This is a firm fixed-price purchase order awarded to Sage Bionetworks, a nonprofit biomedical research organization, by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 7 (VISN 7). The $85,074.37 contract is for research services and does not have a set-aside designation. Sage Bionetworks has a track record of providing technology products and services in support of federal biomedical research programs, including the National Institutes of Health's All of Us...
This is a $8,916,139 cost-no-fee definitive contract awarded by the Food and Drug Administration (FDA) to Embleema Inc. for the development and maintenance of the FDA-ARGOS 2 system, which contains regulatory-grade reference genomes for diagnostic use and regulatory science. The contract is a renewal of a prior-year Broad Agency Announcement (BAA) for Advanced Regulatory Science that the FDA uses to acquire research and development in support of its regulatory mission. There is no set-aside...
This is a definitive $138,204.70 cost-no-fee contract awarded by the Food and Drug Administration (FDA) to the Alliance Nctn Foundation, a non-profit organization and foundation. The contract is for the real-world collection of radiographic images and treatment emergent adverse event data to support the next phase of development of the ICAREDATA research institute. This contract does not have a set-aside designation. Through this work, the Alliance Nctn Foundation serves as a prime contractor...
The U.S. Food and Drug Administration (FDA) awarded a $2,320,370.49 Delivery Order contract to Sagacity Ventures LLC, an SBA-certified 8(a) joint venture that is a minority and women-owned small business. The contract is for subject matter expertise support related to the FDA's Bioresearch Monitoring (BIMO) Program and COVID-19 response efforts. The contract was issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle set aside...
This is a $6,914,101.00 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Beth Israel Deaconess Medical Center, Inc. (Bidmc) on January 19, 2024. The primary objective is to make rich clinical information encoded by billions of real-world laboratory test results available to the public in an effortless yet HIPAA-compliant manner, to advance regulatory science. This contract is not set-aside and has a period of performance through January 18, 2027. Bidmc is...
The Department of Health and Human Services Food and Drug Administration awarded a $3.1 million definitive contract to St. Jude Children's Research Hospital Inc. to conduct modeling of pediatric solid tumors and the tumor microenvironment. This contract was awarded under the agency's fiscal year 2021 Broad Agency Announcement for Advanced Regulatory Science, which sought proposals across eight areas of regulatory science including strengthening social and behavioral research. There was no...
This is a $12,648,281.95 firm fixed-price definitive contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Lasso Informatics US Inc., a small business, for the NIH BRAIN DEVELOPMENT COHORTS DATA SHARING PLATFORM. The contract has a period of performance from April 19, 2024 to April 18, 2025, with a total period of performance through April 18, 2028. The contract is not set aside. The contract will provide a scalable data sharing...